The concept of a green drug, curcumin and it's derivatives as a model system

Mini-Reviews in Organic Chemistry

Volumn 6, Issue 2, 2009, Pages 152-158

  Raja, K S ^a,b   Balambika, R ^a   Dolai, S ^a   Shi, W ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Curcumin; Derivative; GRAS; Green drug; Renewable resource; Traditional medicine

Indexed keywords

MEDICINE;

BIOLOGICALLY ACTIVE COMPOUNDS; CURCUMIN; DRUG DISCOVERY; GRAS; GREEN DRUG; MEDICAL SYSTEMS; MODELLING SYSTEMS; RENEWABLE RESOURCE; SYSTEM USE; TRADITIONAL MEDICINE;

BIOACTIVITY;

EID: 70249116798     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019309788167684     Document Type: Article

References (45)

1. Asif, M.; Muneer, T. Energy supply, its demand and security issues for developed and emerging economies. Renew. Sust. Energy Rev., 2007, 11, 1388-1413.
2. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 2003, 66, 1022-1037.
3. Valiathan, M.S. The Legacy of Caraka, Orient Longman: Hyderabad, 2003.
4. Satyavati, G.V. The legacy of Charaka. Curr. Sci., 2003, 85, 1087-1090.
5. Raja, K.S.; Balambika, R. A Glimpse into World of Siddha Medicine, Library of Congress, USA, 2003.
6. Cordell, G.A.; Farnsworth, N.R.; Beecher, C.W.W.; Soejarto, D.D.; Kinghorn, A.D.; Pezzuto, J.M.; Wall, M.E.; Wani, M.C.; Brown, D.M. In Novel strategies for the discovery of plant-derived anticancer agents; Kinghorn, A.D; Balandrin, M.F., Eds.; Human Medicinal Agents from Plants (ACS Symposium Series No.534); American Chemical Society Books: Washington, 1993, pp.191-204.
7. Lerner, R.A. Manufacturing immunity to disease in a test tube: the magic bullet realized. Angew. Chem. Int. Ed., 2006, 45, 8106-8125.
8. Tang, L.; Shah, S.; Chung, L.; Carney, J.; Katz, L.; Khosla, C.; Julien, B. Cloning and heterologous expression of the epothilone gene cluster. Science, 2000, 287, 640-642.
9. Rouhi, A.M. In Rediscovering Natural Products; Chemical and Engineering News: 2003, vol. 81, pp. 77-78.
10. Rudyard, K. The ballad of east and west; Edmund, C.S., Ed.; A Victorian Anthology, 1895; Available at http://www.barteby.com/246/1129.html
11. Bohacek, R.S.; McMartin, C.; Guida, W.C. The art and practice of structure-based drug design: a molecular modeling perspective. Med. Res. Rev., 1996, 16, 3-50.
12. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70, 461.
13. Borman, S. Organic lab sparks drug discovery. Chem. Engin. News, 2002, vol. 80, pp. 23-24.
14. Singh, S. From exotic spice to modern drug? Cell, 2007, 130, 765-768.
15. Chattopadhyay, I.; Biswas, K.; Bandyopadhyay, U.; Banerjee, R.K. Turmeric and curcumin: Biological actions and medicinal applications. Curr. Sci., 2004, 87, 44-53.
16. Strimpakos, A.S.; Sharma, R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid. Redox Signal., 2008, 10, 511-546.
17. Agarwal, B.B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 2006, 71, 1397-1421.
18. Leyon, P.V.; Kuttan, G. Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J. Exp. Clin. Cancer Res., 2003, 22, 77-83.
19. Shi, W.; Dolai, S.; Rizk, S.; Hussain, A.; Tariq, H.; Averick, S.; L'Amoreaux, W.; El Idrissi, A.; Banerjee, P.; Raja, K. S. Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications. Org. Lett., 2007, 9, 5461-5464.
20. Nurfinal, A.N.; Reksohadiprodjo, M.S.; Timmerman, H.; Jenie, U.A.; Sugiyant, D.; van der Goot, H. Synthesis of some symmetrical curcumin derivatives and their antiinflammatory activity. Eur. J. Med. Chem., 1997, 32, 321-328.
21. Yang, F.; Lim, P.L.G. P.; Begum, A.N.; Ubeda, O.J.; Simmons, M.R.; Ambegaokar, S.S.; Chen, P.; Kayed, R.; Glabe, C.G.; Frautschy, S.A.; Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem., 2005, 280, 5892-5901.
22. Kumar, S.; Narain, U.; Tripathi, S.; Misra, K. Syntheses of curcumin bioconjugates and study of their antibacterial activities against -Lactamase-producing microorganisms. Bioconjugate Chem., 2001, 12, 464-469.
23. Roca, F.; Mauro, L.V.; Morandi, A.; Bonadeo, F.; Vaccaro, C.; Quintana, G.O.; Specterman, S.; Kier-Joffe, E.B.; Pallotta, M.G.; Puricelli, L.I.; Shishodia, S.; Amin, H.M.; Lai, R.; Aggarwal, B.B. Curcumin (diferu-loylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol., 2005, 70, 700-713.
24. Cole, G.M.; Teter, B.; Frautschy, S. A. Neuroprotective effects of curcumin. Adv. Exp. Med. Biol., 2007, 595, 197-212.
25. Cheng, A.L.; Hsu, C.H.; Lin, J.K.; Hsu, M.M.; Ho, Y.F.; Shen, T.S.; Ko, J.Y.; Lin, J.T.; Lin, B.R.; Wu, M.S.; Yu, H.S.; Jee, S.H.; Chen, G.S.; Chen, T.M.; Chen, C.A.; Lai, M.K.; Pu, Y.S.; Pan, M.H.; Wang, Y.J.; Tsai, C.C.; Hsieh, C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res., 2001, 21, 2895-2900.
26. Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm., 2007, 4, 807-818.
27. Pfeiffer, E.; Hoehle, S.I.; Walch, S.G.; Riess, A.; Solyom, A.M.; Metzler, M. Curcuminoids form reactive glucuronides in vitro. J. Agric. Food Chem., 2007, 55, 538-544.
28. Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med., 1998, 64, 353-356.
29. Bisht, S.; Feldmann, G.; Soni, S.; Ravi, R.; Karikar, C.; Maitra, A.; Maitra, A. Polymeric nanoparticle-encapsulated curcumin (nano-curcumin): a novel strategy for human cancer therapy. J. Nanobiotechnol., 2007, 5, 3.
30. Tiyaboonchai, W.; Tungpradit, W.; Plianbangchang, P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm., 2007, 337, 299-306.
31. Li, L.; Braiteh, F.S.; Kurzrock, R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer, 2005, 104, 1322-1331.
32. Li, L.; Ahmed, B.; Mehta, K.; Kurzrock, R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol. Cancer Ther., 2007, 6, 1276.
33. Maiti, K.; Mukherjee, K.; Gantait, A.; Saha, B.P.; Mukherjee, P.K. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharma-cokinetic study in rats. Int. J. Pharm. 2007, 330, 155-163.
34. Kumar, V.; Lewis, S.A.; Mutalik, S.; Shenoy, D.B.; Venkatesh; Udupa, N. Biodegradable microspheres of curcumin for treatment of inflammation. Indian J. Physiol. Pharmacol., 2002, 46, 209-217.
35. Ma, Z.; Shayeganpour, A.; Brocks, Dion R.; Lavasanifar, A.; Samuel, J. High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed. Chromatogr., 2007, 21, 546-552.
36. Mosley, C.A.; Liotta, D.C.; Snyder, J.P. Highly active anticancer curcumin analogues. Adv. Exp. Med. Biol., 2007, 595, 77-103.
37. Thompson, K.H.; Böhmerle, K.; Polishchuk, E.; Martins, C.; Toleikis, P.; Tse, J.; Yuen, V.; McNeill, J.H.; Orvig, C. Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. J. Inorg. Biochem., 2004, 98, 2063-2070.
38. Sharma, K.K.; Chandra, S.; Basu, D.K. Synthesis and antiarthritic study of a new orally active diferuloyl methane (curcumin) gold complex. Inorg. Chim. Acta, 1987, 135, 47-48.
39. Krishnankutty, K.; Venugopal, P. Metal chelates of curcuminoids. Synth. React. Inorg. Met. Org. Chem., 1998, 28, 1313-1325.
40. Barik, A.; Mishra, B.; Kunwar, A.; Kadam, R.M.; Shen, L.; Dutta, S.; Padhye, S.; Satpati, A.K.; Zhang H.Y.; Priyadarsini K. I. Comparative study of copper(II)-curcumin complexes as superoxide dismutase mimics and free radical scavengers. Eur. J. Med. Chem., 2007, 42, 431-439.
41. Vajragupta, O.; Boonchoong, P.; Watanabe, H.; Tohda, M.; Kammasud, N.; Sumanont, Y. Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. Free Radic. Biol. Med., 2003, 35, 1632.
42. Ryu, E.K.; Choe, Y.S.; Lee, K.H.; Choi, Y.; Kim, B.T. Curcumin and dehy-drozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J. Med. Chem., 2006, 49, 6111-6119.
43. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B.A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective ligation of azides and terminal alkynes. Angew. Chem. Int. Ed., 2002, 41, 2596-2599.
44. Safavy, A.; Raisch, K.P.; Mantena, S.; Sanford, L.L.; Sham, S.W.; RamaKrishna, N.; Bonner, J.A. Design and development of water-soluble curcumin conjugates as potential anticancer agents. J. Med. Chem., 2007, 50, 6284-6288.
45. Pardridges, W.M.; Boado, R.J.; Farrell, C.R. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative Western blotting and in situ hybridization. J. Biol. Chem., 1990, 265, 18035-18040.